Adult Giant Cell Glioblastoma Trials in pittsburgh, united states
Conditions / Adult Giant Cell Glioblastoma / pittsburgh, united states
Adult Giant Cell Glioblastoma has been the subject of sustained clinical investigation across multiple research sites.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00268385 | Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT00731731 | Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | COMPLETED | PHASE1/PHASE2 |
| NCT00112736 | Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma | COMPLETED | PHASE1/PHASE2 |
| NCT00650923 | Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma | COMPLETED | PHASE1 |
| NCT00085540 | FR901228 in Treating Patients With Recurrent High-Grade Gliomas | COMPLETED | PHASE1/PHASE2 |
| NCT00335764 | Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma | COMPLETED | PHASE1/PHASE2 |
| NCT00045110 | Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma | COMPLETED | PHASE1/PHASE2 |
| NCT01730950 | Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma | COMPLETED | PHASE2 |
| NCT00369590 | VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide | COMPLETED | PHASE2 |
| NCT00459381 | Pazopanib in Treating Patients With Recurrent Glioblastoma | COMPLETED | PHASE2 |